Diabetic Neuropathic Foot Ulcers Market Size, Competitive Landscape and Market Forecast - 2029

SKU: DMPH28 | Last Updated On: Jun 13 2022 | Available Formats

> Global Diabetic Neuropathic Foot Ulcers Market Expected to reach a high CAGR of 12.1% during the forecast period 2022-2029: DataM Intelligence

Global Diabetic Neuropathic Foot Ulcers Market is Segmented By Treatment Type (Wound Care Dressings, Biologics, Foam Dressing, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, Other Dressing, Biologics, Growth Factors, Skin Graft and Skin Substitutes, Others), By End User(Hospitals, Specialty Clinics, Long term Care Centers, Ambulatory Surgical Centers, Home Care setting), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029


Market Overview

The Global Diabetic Neuropathic Foot Ulcers Market is expected to grow at a CAGR of 12.1% during the forecasting period (2022-2029).

  • Foot ulceration is a major and serious complication of diabetes, affecting 12% to 15% of patients with diabetes mellitus during their lifetime.

  • Diabetic Neuropathic Foot Ulcers generally develop on the plantar part of the foot or toes as a result of the loss of peripheral sensation.

Market Growth and Trends

  • The Global Diabetic Neuropathic Foot Ulcers market is estimated to reach over USD 3 billion by 2024.

  • The dramatically increasing prevalence of diabetes will greatly increase the patient pool for Diabetic Neuropathic Foot Ulcers, thereby driving the market growth.

  • According to the International Diabetes Federation (IDF), the number of people with diabetes worldwide was estimated at 366 million in 2011 and is expected to rise to 522 million in 2030.

  • The rising incidence of diabetic foot ulcers has compelled healthcare providers and patients’ families to focus on preventive measures to curb any additional expenditure and discomfort.

  • This could have a negative impact on market growth.

Market Segmentation

  • Global Diabetic Neuropathic Foot Ulcers market report segments the market by treatment type, end-user, and region.

  • Based on treatment type, the market is categorized into wound care dressings, biologics, and others.

  • Biologics are increasingly used for the treatment of diabetic foot ulcers

  • Regionally, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW.

  • North America will dominate the market due to the high prevalence of diabetes, high awareness among people about Diabetic Neuropathic Foot Ulcers, availability of treatment options, and better reimbursement policies in the region.

Scope of the report:

  • The report also profiles companies in the Diabetic Neuropathic Foot Ulcers market – B. Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis, Inc., Derma Sciences Inc., Sigvaris Inc., 3M, Acelity L.P. Inc., Innocoll Holdings plc., SIGVARIS, Inc., and Osiris.

By Treatment Type

  • Wound Care Dressings

  • Biologics

  • Others

By End-User

  • Hospitals

  • Specialty Clinics

  • Long term Care Centres

  • Ambulatory Surgical Centres

  • Home Care setting

By Region

  • Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)

  • Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)

  • North America (The USA, Canada, Mexico)

  • South America (Brazil, Argentina, Rest of South America)

  • Rest of the World

Trending Topics

Foam Dressings Market

Pressure Ulcers Market

Remote Patient Monitoring Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!